Chronic pancreatitis involves progressive inflammation and fibrosis, with early-stage mechanisms and biomarkers remaining poorly understood, hindering disease-modifying treatments.
- 1 cites
Moving in Gastroenterology, New England Journal of Medicine, Blood, Cell Stem Cell, Gut, Journal of hepatology, medRxiv, The Lancet.
Rebuilt
Nothing in this area has moved yet this week.
Newest first · last 60 days
Chronic pancreatitis involves progressive inflammation and fibrosis, with early-stage mechanisms and biomarkers remaining poorly understood, hindering disease-modifying treatments.
Obexelimab significantly delays disease flares and reduces glucocorticoid use in IgG4-related disease, with a hazard ratio of 0.44 and fewer flares compared to placebo.
Patient-derived organoids reveal widespread CFTR dysfunction in half of chronic pancreatitis cases, including those with wild-type CFTR, and respond to CFTR modulators.
Journals this month
Moving areas, week to 3 Oct 2026